By Doug Madison Zacks Investment Research upgraded shares of CONMED (NASDAQ:CNMD) from a strong sell rating to a hold rating in a research note issued to investors on Thursday morning, AnalystRatingsNetwork.com reports. According to Zacks, “We are disappointed with CONMED’s third quarter results which fell short of expectations